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Outcomes of Convergent Ablation Procedure using a Cryo-balloon 
Catheter for Treatment of Persistent Atrial Fibrillation
Research Question: Does the use of a cryo-balloon catheter during the 
endocardial portion of a convergent procedure elicit greater success 
rates towards eliminating recurrent atrial fibrillation than using a 
radiofrequency catheter?  
Background:Traditional catheter based treatment for atrial fibrillation 
(AF) uses radiofrequency as a source of energy for the ablation of atrial 
tissue.  This is an endocardial (inside the heart) technique.  The success 
rate of this technique at one year is around 50-60%1. In the last three 
years, a novel technology using a combined/hybrid trans-diaphragmatic 
surgical epicardial (outside the heart) ablation with endocardial (inside 
the heart) ablation has had one-year success rates close to 80%2.  This 
is called the Convergent Procedure (CP) 3. The CP can be done with 
either radiofrequency ablation (RF), or with a cryo-balloon catheter to 
create the endocardial lesion set. The cryo-balloon technique may be a 
preferred approach, as it improves endocardial coverage of the 





• AF patients are treated medically, through cardioversions, and/or with traditional 
ablations. 
• If all these treatment options continue to fail, patients are considered appropriate 
candidates for the convergent procedure.
Epicardial
Ablation
• A cardiothoracic surgeon  enters the peritoneal cavity with a radiofrequency ablation 
device through a small incision approx. 2 cm below the xiphoid process. 
• The surgeon ablates the posterior aspect of the heart in a linear fashion from the left 
pulmonary veins to the right pulmonary veins 
Endocardial
Ablation
• An electrophysiologist positions a cryo-balloon catheter in each of the four ostia of the 
pulmonary veins, ensuring occlusion via ICE imaging and lack of color flow. 
• The cryo-balloon is then inflated with a liquid refrigerant that evaporates and scars the 
tissue of the pulmonary vein, thus  eliminating any electrical conduction that could 




• After surgery, patients were started on amiodarone, steroids, anticoagulants, and anti-
inflammatories
• At the follow-up, patients’ monitoring devices were interrogated and ECGs were 
administered to determine heart rhythm. 
• Medication was adjusted as needed. 
From October 2013 to May 2016, 45 AF patients underwent the 
convergent procedure with cryo-balloon endocardial ablation at LVHN. 
Patients were managed postoperatively medically  and followed up with 
in the office 1 month, 3 months, 6 months, and 12 months after the 
surgery. Most (87%) patients received an implantable monitoring device 
that was interrogated at each visit for arrhythmias. Medical records 
were reviewed to determine pre-operative comorbidities and post-
operative outcomes. 
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Data Analysis 
The bar graph depicts the percentage of LVHN patients that were free 
of AF post convergent procedure compared to similar data from various 
studies.
The first Kaplan Meier curve estimates the likelihood of maintaining 
atrial fibrillation-free status post convergent procedure over time.. After 
receiving the convergent procedure with cryoballoon catheter, 75.56% 
(34) of patients did not experience a recurrent AF episode, while 
24.44% (11) had experienced at least one recurrent AF episode.
The second Kaplan Meier curve  estimates the likelihood of being in 
sinus rhythm at the most recent follow up, postoperatively. 82.22% (37) 
patients were not experiencing a recurrent AF episode at the time of 
the most recent follow-up and 17.78% (8) were experiencing a recurrent 
AF episode at the time of follow up.
Procedural Complications
– A total of three patients (6.7%) experienced rare adverse 
effects from the operation. 
– One patient suffered from pericardial effusion and one from a 
hemoperitoneum with bleeding around trocar sites.
– Both patients recovered successfully.
– Another patient experienced bleeding from groin puncture, and 
required factor VII. 
– This patient had two failed cardioversions postoperatively
– There were no procedural mortalities, no atrioesophogeal
fistulas, and no pericardial tamponade. 
Study limitations
– A retrospective review of symptomatic AF patients that 
received Convergent Procedure with a cryo-balloon ablation
– No quality of life survey administered.
– No control group. Utilized literature review. 
– Some patients underwent their CP less than a year before the 
conduction of study. Thus, limited follow-up data was available.  
This study of 45 patients suggests that the use of a cyro-balloon 
catheter for endocardial ablation during the convergent procedure is a 
viable method to eliminate the recurrence of persistent atrial fibrillation 
and arrhythmias. 
Other data should be collected on the time and cost efficiency of the 
cryo-balloon versus radiofrequency technique.
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